Christopher J. Dinsmore

3.4k citations

47 papers · 1.8k indexed · h-index 25

Co-authors: Douglas C. Beshore David A. Evans Thomas R. Hoye Deborah A. Evrard Swati P. Mercer Jeffrey L. Katz B. Wesley Trotter Paul S. Watson
Topics: Chemical Synthesis and Analysis (13 papers)Microbial Natural Products and Biosynthesis (7 papers)Protein Kinase Regulation and GTPase Signaling (6 papers)
Cited by: Process Chemistry and Technology Organic Chemistry Inorganic Chemistry
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Angewandte Chemie International Edition
Partner nations: United States Switzerland

In The Last Decade

Christopher J. Dinsmore

47 papers receiving 1.7k citations

Peers

Countries citing papers authored by Christopher J. Dinsmore

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Dinsmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Dinsmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Dinsmore more than expected).

Fields of papers citing papers by Christopher J. Dinsmore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Dinsmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Dinsmore. The network helps show where Christopher J. Dinsmore may publish in the future.

Co-authorship network of co-authors of Christopher J. Dinsmore

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Dinsmore. A scholar is included among the top collaborators of Christopher J. Dinsmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Dinsmore. Christopher J. Dinsmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FT-4202, a selective pyruvate kinase R activator for sickle cell disease 2024 ·Experimental Hematology ·Anna Ericsson,David J. Richard,Erik Wilker,(unknown),Shawn P. Fessler,(unknown),Xiaozhang Zheng,Angela V. Toms,Christopher J. Dinsmore,Lili Yao,Frans A. Kuypers,Sandra Larkin,D.J. Marcotte,Keertik Fulzele,Maria Ribadeneira,Sylvie M. Guichard,Gary R. Marshall	1
2	Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor 2020 ·Journal of Medicinal Chemistry ·Justin A. Caravella,(unknown),R. Bruce Diebold,(unknown),Anna Ericsson,Gary Gustafson,Zhongguo Wang,(unknown),Andrea Clarke,Deepali Gotur,Helen R. Josephine,(unknown),Mark T. Kershaw,Lili Yao,Angela V. Toms,Kenneth J. Barr,Christopher J. Dinsmore,Duncan Walker,Susan Ashwell,Wei Lu	111
3	Structure-based design and development of (benz)imidazole pyridones as JAK1-selective kinase inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Sujal V. Deshmukh,Christopher J. Dinsmore,Fiona Elwood,Rafael Fernández,(unknown),(unknown),Hakan Günaydin,Joon Jung,Jason D. Katz,Brian Kraybill,(unknown),Sangita B. Patel,Tony Siu,Hua-Poo Su,Jonathan R. Young	18
4	The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: Lead optimization 2014 ·Bioorganic & Medicinal Chemistry Letters ·Tony Siu,(unknown),Michael D. Altman,Matthew H. Katcher,Alan B. Northrup,Catherine A. White,Craig Rosenstein,(unknown),Lin Xu,Grace Chan,Eric Bachman,(unknown),Christopher J. Dinsmore,C. Gary Marshall,Jonathan R. Young	6
5	Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel 2010 ·Bioorganic & Medicinal Chemistry Letters ·Douglas C. Beshore,Nigel J. Liverton,Charles McIntyre,Christopher F. Claiborne,Brian E. Libby,Joseph Culberson,Joseph J. Salata,Christopher P. Regan,Joseph J. Lynch,László Kiss,Robert H. Spencer,(unknown),Rebecca B. White,Suzie Yeh,George D. Hartman,Christopher J. Dinsmore	12
6	The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: Hit to lead 2010 ·Bioorganic & Medicinal Chemistry Letters ·Tony Siu,(unknown),Joon Jung,Craig Rosenstein,(unknown),Michael D. Altman,Grace Chan,Lin Xu,Eric Bachman,Jan-Rung Mo,(unknown),Thomas S. Rush,Christopher J. Dinsmore,C. Gary Marshall,Jonathan R. Young	22
7	Parallel Synthesis of Ureas and Carbamates from Amines and CO₂ under Mild Conditions 2010 ·Organic Letters ·(unknown),(unknown),Christopher J. Dinsmore	142
8	Potent antagonists of the Kv1.5 potassium channel: Synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamides 2006 ·Bioorganic & Medicinal Chemistry Letters ·Kausik K. Nanda,(unknown),Matthew J. Cato,Stefanie A. Kane,László Kiss,Robert H. Spencer,Jixin Wang,Joseph J. Lynch,Christopher P. Regan,Gary L. Stump,Bing Li,Rebecca B. White,Suzie Yeh,Michael J. Bogusky,Mark T. Bilodeau,Christopher J. Dinsmore,Craig W. Lindsley,George D. Hartman,S. E. Wolkenberg,B. Wesley Trotter	11
9	Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I 2004 ·Bioorganic & Medicinal Chemistry Letters ·Christopher J. Dinsmore,C. Blair Zartman,Jeffrey M. Bergman,Marc Abrams,Carolyn A. Buser,Joseph Culberson,Joseph P. Davide,Michelle Ellis-Hutchings,Christine Fernandes,Samuel Graham,George D. Hartman,Hans E. Huber,Robert B. Lobell,Scott D. Mosser,R. Robinson,Theresa M. Williams	8
10	Inhibitors of Farnesyltransferase and Geranylgeranyltransferase-I for Antitumor Therapy: Substrate-Based Design, Conformational Constraint and Biological Activity 2003 ·Current Topics in Medicinal Chemistry ·Christopher J. Dinsmore,Ian M. Bell	26
11	Preparation of Ethyl 5-Iodo-1H-indole- 2-carboxylate 2003 ·Synthetic Communications ·Douglas C. Beshore,Christopher J. Dinsmore	7
12	Anions Modulate the Potency of Geranylgeranyl-Protein Transferase I Inhibitors 2001 ·Journal of Biological Chemistry ·Hans E. Huber,R. Robinson,(unknown),Deborah D. Nahas,Marc Abrams,Carolyn A. Buser,Robert B. Lobell,D Patrick,Neville J. Anthony,Christopher J. Dinsmore,Samuel Graham,George D. Hartman,William C. Lumma,Theresa M. Williams,David Heimbrook	16
13	Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey M. Bergman,Marc Abrams,Joseph P. Davide,Ian Greenberg,R. Robinson,Carolyn A. Buser,Hans E. Huber,Kenneth S. Koblan,Nancy E. Kohl,Robert B. Lobell,Samuel Graham,George D. Hartman,Theresa M. Williams,Christopher J. Dinsmore	25
14	High-Performance Liquid Chromatography/Mass Spectrometry Characterization of Ki4B-Ras in PSN-1 Cells Treated with the Prenyltransferase Inhibitor L-778,123 2001 ·Analytical Biochemistry ·Carolyn A. Buser,Christopher J. Dinsmore,Christine Fernandes,Ian Greenberg,Kelly Hamilton,Scott D. Mosser,Eileen S. Walsh,Theresa M. Williams,Kenneth S. Koblan	24
15	3,8-Diazabicyclo[3.2.1]octan-2-one Peptide Mimetics: Synthesis of a Conformationally Restricted Inhibitor of Farnesyltransferase 2001 ·Organic Letters ·Christopher J. Dinsmore,Jeffrey M. Bergman,Michael J. Bogusky,Joseph Culberson,Kelly Hamilton,Samuel Graham	25
16	Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase 1999 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Suzanne C. MacTough,Theresa M. Williams,Christopher J. Dinsmore,Timothy J. O’Neill,(unknown),Joseph Culberson,Kenneth S. Koblan,Nancy E. Kohl,W. Wayt Gibbs,Allen Oliff,Samuel Graham,George D. Hartman	28
17	Arylmethanesulfonates are convenient latent phenols in the nucleophilic aromatic substitution reaction 1999 ·Tetrahedron Letters ·Christopher J. Dinsmore,C. Blair Zartman	11
18	Nonconventional Stereochemical Issues in the Design of the Synthesis of the Vancomycin Antibiotics: Challenges Imposed by Axial and Nonplanar Chiral Elements in the Heptapeptide Aglycons 1998 ·Angewandte Chemie International Edition ·David A. Evans,Christopher J. Dinsmore,Paul S. Watson,Michael R. Wood,Timothy I. Richardson,B. Wesley Trotter,Jeffrey L. Katz	139
19	Mild nitrosation and hydrolysis of polyfunctional amides 1997 ·Tetrahedron Letters ·David A. Evans,Percy H. Carter,Christopher J. Dinsmore,James C. Barrow,Jeffrey L. Katz,Daniel W. Kung	52
20	DIARYLETHER INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE 1997 ·Bioorganic & Medicinal Chemistry Letters ·Christopher J. Dinsmore,Theresa M. Williams,Kelly Hamilton,Timothy J. O’Neill,Elaine Rands,Kenneth S. Koblan,Nancy E. Kohl,W. Wayt Gibbs,Samuel Graham,George D. Hartman,Allen Oliff	7

About Christopher J. Dinsmore

Christopher J. Dinsmore is a scholar working on Organic Chemistry, Process Chemistry and Technology and Genetics, having authored 47 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (13 papers), Microbial Natural Products and Biosynthesis (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). The work is most often cited by research in Process Chemistry and Technology (175 citations), Organic Chemistry (1.3k citations) and Inorganic Chemistry (188 citations). Christopher J. Dinsmore has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Douglas C. Beshore, David A. Evans, Thomas R. Hoye, Deborah A. Evrard, Swati P. Mercer, Jeffrey L. Katz, B. Wesley Trotter, Paul S. Watson, Keith M. DeVries and James C. Barrow. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact